胺碘酮与洋地黄治疗快速心房颤动疗效比较被引量：2

导出

摘要目的比较胺碘酮与洋地黄治疗快速心房颤动的疗效与安全性。方法92例房颤患者,随机分为胺碘酮组与洋地黄组。胺碘酮组首剂量给予3mg/kg静脉推注,其后0.8～1mg/min维持,24h总剂量700～1000mg。洋地黄组:近1周未用地戈辛者,予毛花甙C0.2mg静脉推注,30min无效者追加0.2mg,30min仍无效再追加0.2mg,总剂量不大于1.2mg。近1周服用地戈辛者,开始予毛花甙C0.2mg静脉推注,30min无效者追加0.2mg,30min仍无效再追加0.2mg,总剂量不大于0.6mg。结果两组比较,胺碘酮组、洋地黄组控制心室率总有效率分别为83%、61%,心室率平均下降幅度为35%和21%,平均起效时间分别为(14±10)min、(30±5)min。两组均有1例出现症状性低血压。结论胺碘酮能安全、有效控制房颤心室率。

作者马孝涛

机构地区贵州省贵阳市乌当区人民医院

出处《中国实用医药》 2008年第29期119-120,共2页 China Practical Medicine

关键词胺碘酮毛花甙C 心房颤动心室率

分类号 R541.75 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1王学英,柳景华.洋地黄治疗心力衰竭再认识[J].中国心血管病研究,2005,3(6):465-467. 被引量：13
2[4]Clemo HF,Wood MA,Gilligan DM,et al.Intravenous fenopraine for acute heart rate control in the critically ill patients with atrial tackyarrhythmiss.Am J Cardial,1998,81:594-598.
3[5]KhandA U,Rankin AC,Kaye GC.Systematic review of the management of atrial fibrillation in patients with heart fallure.Eur Heart J,2000,21:614-632.
4[6]Jordaens L,Trouerbach J,Calle P,et al.Conversion of atrial fibrillations to sinusrhythm and rate control by digoxin in comparison to placebo.Eur Heart J,1997,18(4):643-648.
5[7]Murphy MT,Wilkoff BL.What internists should know about amiodarone.Cleve Clin J Med,1998,65:159-166.
6[8]Scheinman MM,Levine JH,Cannom DS,et al.Dose-ranging study of intravenous amiodarone in patients with life-threatening vetricular tachyarrhythmias.The intravenous Amiodarone Multicenter Investigators Group.Circulation,1995,92(11):3264.
7[9]White CM,Dunn A,Tsikouris J,et al.An assesment of the safety of short term amiodarone therapy in cardiac surgical patients with fentanyl-isoflurane anesthesia.Anesth Analg,1999,89(3):585.

二级参考文献15

1[12]Uretsky BF, Young JB, Shahidi E, et al. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure:Results of the proved trial. J Am Coll Cardiol, 1993,22: 955-962
2[13]Packer M, Gheorghiade M,Young JB,et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med, 1993,329: 1-7
3[14]Adams KF,Gheorghiade M,Uretsky BF,et al. Patients with mild heart failure worsen during withdrawal from digoxin therapy.J Am Coll Cardiol, 1997,30: 42-48
4[15]Slatton ML,Iranl WN, Hall SA,et al. Does igoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol, 1997,29:1206-1213
5[16]Young JB. Dodigitalis glycosides still have a role in congestive heart failure? Cardiol Clin, 1994, 12:51-62
6[1]Rahimtoola SH,Tak T.The use of digitalis in heart failure.Curr Probl Cardiol, 1996,21: 781-756
7[2]Khand AU,Rankin AC,Martin W,et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure.J Am Coll Cardiol, 2003,42: 1944-1951
8[3]Uretsky BF, Young JB, Shahidi FE,et al. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure:results of the PROVED Trial.J Am Coll Cardiol, 1993,22:955-962
9[4]Packer M,Gheorghiade M,Young JB,et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med, 1993,329: 1-7
10[5]Digitalis Investigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med, 1997,336: 525-533